Logo Logo Logo Logo Logo Logo
  • Home
  • Team
  • Technology
  • Science
  • News
  • Partnering
  • Funding
  • Career

Author: p539124

07 June, 2023 Allgemein
Pantherna Therapeutics teams up with University Medicine Rostock (UMR) on exploring new opportunities for mRNA therapy in ocular disease
08 February, 2023 Allgemein
Evaxion and Pantherna announce promising preclinical mRNA vaccine data
04 October, 2022 Allgemein
Astellas and Pantherna Enter into a New Technology Evaluation Agreement for Research with Expanded Target Organ to Generate mRNA-Based Regenerative Medicine Programs Using Direct Reprogramming
19 September, 2022 Uncategorized
Pantherna among Pharma Trend award winners
05 September, 2022 Allgemein
Pantherna Therapeutics collaborates with Charité – Universitätsmedizin Berlin to investigate the potential of therapeutic mRNA in autoimmune disease
25 July, 2022 Uncategorized
Meet Pantherna Therapeutics at BIO-Europe 2022
11 January, 2022 Uncategorized
Pantherna Therapeutics secures EUR 4.0 Mio. follow-on financing to advance its therapeutic mRNA development programs 
15 November, 2021 Allgemein
Astellas and Pantherna Enter into Technology Evaluation Agreement for Research of mRNA-based Regenerative Medicine.
28 May, 2021 Allgemein
Pantherna Therapeutics to be granted 2.2 millions EFRE public funding.
12 June, 2020 Allgemein
Pantherna Therapeutics GmbH signs an agreement for technology evaluation with Astellas Innovation Management LLC to evaluate Pantherna’s lipid nanoparticle transport system and mRNA molecules.
  • 1
  • 2
  • 3
Privacy Policy | Imprint